期刊文献+

α-半乳糖苷酶A活性检测与Fabry病诊断筛查 被引量:7

Value of α-galactosidase A activity assay in diagnosis and screening of Fabry's disease
下载PDF
导出
摘要 目的:建立α-半乳糖苷酶A(α-GalA)活性的检测方法,为Fabry病的诊断和筛查提供依据。方法:分别采用外周血粒细胞和干燥血滴滤纸片(干血片)检测11个家系15例Fabry病患者和30名健康者的α-GalA活性,检测采用底物荧光法。比较Fabry病患者组与健康对照组间、干血片法不同保存时间组间的酶活性,并建立酶活性正常参考范围,计算2种检测酶活性方法的灵敏度。结果:正常人干血片酶活性为(3.68±0.98)nmol/(ml·h),粒细胞酶活性为(46.21±8.56)nmol/(h·mg),两者正常参考范围分别为≥1.68nmol/(ml·h)、≥25.45nmol/(h·mg)。男性半合子患者酶活性显著下降(P<0.001),干血片酶活性值<0.15nmol/(ml·h)、粒细胞酶活性值<1nmol/(h·mg),酶活性的2种检测方法在男性半合子患者中的灵敏度为100%。在女性杂合子患者酶活性部分下降,4例女性杂合子患者中3例干血片检测酶活性的结果、2例检测外周血粒细胞酶活性的结果处于正常范围,检测女性杂合子干血片和粒细胞酶活性的灵敏度分别为25%和50%。干血片在室温下保存3、14和28d后酶活性值分别为(3.63±0.96)nmol/(ml·h)、(3.60±0.88)nmol/(ml·h)和(3.06±0.68)nmol/(ml·h),残余酶活性值大于基线值80%,显著高于男性半合子酶活性值(P<0.001)。结论:干血片检测酶活性更简易、快速、经济,便于保存运输,可用于高危人群筛查,外周血粒细胞酶活性测定对女性杂合子灵敏度更高,测定值更精确,适于家系筛查研究。酶活性检测可有效诊断和筛查男性半合子Fabry病患者。 Objective To set up enzymatic assay methods of α-galactosidase A (α-Gal A) for diagnosis and screening of Fabry's disease (FD). Methods Fifteen patients with FD and 30 healthy controls were recruited, α-Gal A enzymatic activity in dried blood spots on filter paper (DBFP) and in peripheral leukocytes was measured by fluorogenic substrate,4-methylumbelliferyl-α-D-galactopyranoside in the two groups. Difference of data between FD patients and normal controls was analyzed, normal reference value range was defined and the sensitivity of both assay methods was evaluated. Results Enzymatic activity in DBFP and peripheral leukocytes was (3.68±0.98)nmol/(ml-h) and (46.21±8.56)nmol/(h .mg). Normal reference value of enzymatic activity is over 1.68 nmol/(ml·h) in DBSP and over 25.45 nmol/(h·mg) in leukocytes. All the hemizygotes showed low enzymatic activity with both methods, showing sensitivity of 100% in hemizygotes. 3/4 of heterozygotes had the enzymatic activity within normal range in DBFP (sensitivity:25%), while 1/2 within normal range in leukocyte (sensitivity:50%). Conclusions Enzymatic diagnosis in dried blood is easier, faster and less expensive than the leukocyte assay and it appears to be a reasonable approach for the screening high risk populations of FD, while leukocyte assay has more accuracy and higher sensitivity in heterozygotes. Enzymatic activity in DBFP and peripheral leukocytes is of significant importance in diagnosis and screening of FD.
出处 《诊断学理论与实践》 2007年第5期417-420,共4页 Journal of Diagnostics Concepts & Practice
基金 上海市重点学科(T0201) 上海市卫生局重点学科基金(05Ⅲ001) 上海市卫生局重点课题(2003ZD002) 上海市青年科技启明星培养计划(03QD14021)
关键词 FABRY病 诊断 筛查 Α-半乳糖苷酶A 干燥血滴滤纸片 Fabry's disease diagnosis and screening Alpha-galactosidase A Dried blood spots on filter paper
  • 相关文献

参考文献14

  • 1[1]Spada M,Pagliardini S,Yasuda M,et al.High incidence of later-onset fabry disease revealed by newborn screening[J].Am J Hum Genet,2006,79(1):31-40.
  • 2[2]Desnick R J,Brady R,Barranger J,et al.Fabry disease,an under-recognized multisystemic disorder:expert recommendations for diagnosis,management,and enzyme replacement therapy[J].Ann Intern Med,2003,138(4):338-346.
  • 3陈佳韵,王朝晖,潘晓霞,王伟铭,任红,陈晓农,巫永睿,陆颖,陈楠.Fabry病家系的α-半乳糖苷酶A基因突变研究[J].中华肾脏病杂志,2005,21(11):654-658. 被引量:14
  • 4陈佳韵,潘晓霞,吕轶伦,王朝晖,王伟铭,任红,张文,翁崎峻,陈楠.11个Fabry病家系的α-半乳糖苷酶A活性及GLA基因检测[J].中华肾脏病杂志,2007,23(5):302-307. 被引量:17
  • 5[5]Chamoles NA,Blanco M,Gaggioli D.Fabry disease:enzymatic diagnosis in dried blood spots on filter paper[J].Clin Chim Acta,2001,308(1-2):195-196.
  • 6[6]Desnick RJ,Allen KY,Desnick SJ,et al.Fabry's disease:enzymatic diagnosis of hemizygotes and heterozygotes.Alpha-galactosidase activities in plasma,serum,urine,and leukocytes[J].J Lab Clin Med,1973,81(2):157-171.
  • 7[7]Eng CM,Fletcher J,Wilcox WR,et al.Fabry disease:baseline medical characteristics of a cohort of 1765 males and females in the Fabry Registry[J].J Inherit Metab Dis,2007,30(2):184-192.
  • 8[8]Deegan PB,Baehner AF,Barba Romero MA,et al.Natural history of Fabry disease in females in the Fabry Outcome Survey[J].J Med Genet,2006,43(4):347-352.
  • 9[9]Linthorst GE,Vedder AC,Aerts JM,et al.Screening for Fabry disease using whole blood spots fails to identify one-third of female carriers[J].Clin Chim Acta,2005,353(1-2):201-203.
  • 10[10]Schiffmann R.Natural history of Fabry disease in males:preliminary observations[J].J Inherit Metab Dis,2001,24(Suppl 2):15-17.

二级参考文献31

  • 1陈佳韵,王朝晖,潘晓霞,王伟铭,任红,陈晓农,巫永睿,陆颖,陈楠.Fabry病家系的α-半乳糖苷酶A基因突变研究[J].中华肾脏病杂志,2005,21(11):654-658. 被引量:14
  • 2Desnick RJ. Alpha galactosidase A deficiency: Fabry disease.In: Scriver CR, Beaudet AL, Sly WS, eds. The metabolic and molecular bases of inherited disease. 8th ed. New York:McGraw-Hill, 2001. 3733-3774.
  • 3Brady RO, Schiffmann R. Clinical features and recent advances in therapy for Fabry disease. JAMA, 2000, 284:2771-2775.
  • 4Stenson PD, Ball EV, Mort M. Human Gene Mutation Database (HGMD). 2003 update. Hum Mutat, 2003, 21:577-581.
  • 5Tse KC, Chen KW, Tin VP. Clinical features and genetic analysis of a Chinese kindred with Fabry's disease. Nephrol Dial Transplant, 2003, 18: 182-186.
  • 6Meikle PJ, Hopwood J J, Clague AE. Prevalence of lysosomal storage disorders. JAMA, 1999, 281:249-54.
  • 7Mehta A, Ricci R, Widmer U, et al. Fabry disease defined:baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. Eur J Clin Invest, 2004, 34: 236-242.
  • 8MacDermot KD, Holmes A, Miners AH. Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females. J Md Genet, 2001, 38:769-807.
  • 9Kornreich R, Desnick RJ, Bishop DE. Nucleotide sequence of the human alpha-galactosidase A gene. Nucleic Acids Res,1989, 17: 3301-330.
  • 10Matsuzawa F, Aikawa S, Doi H, et al. Fabry disease:correlation between structural changes in alpha-galactosidase,and clinical and biochemical phenotypes. Hum Genet, 2005,117: 317-38.

共引文献26

同被引文献97

  • 1张苏华,刘志红,李世军,陈惠萍,苏健,曾彩虹,黎磊石.Fabry病的临床表现及肾脏病理学特征[J].肾脏病与透析肾移植杂志,2004,13(6):517-523. 被引量:16
  • 2陈佳韵,王朝晖,潘晓霞,王伟铭,任红,陈晓农,巫永睿,陆颖,陈楠.Fabry病家系的α-半乳糖苷酶A基因突变研究[J].中华肾脏病杂志,2005,21(11):654-658. 被引量:14
  • 3刘和俊,曹克将,李诚让,戴健,马继政,雍永宏,孙伟.肥厚型心肌病样临床表现的FABRY病家系研究[J].中华心血管病杂志,2006,34(2):143-147. 被引量:6
  • 4刘晓曼,安丰双,张运,张澄,安贵鹏,颜墨磊,杨兴胜,王荣.PCR-SSCP技术在Anderson Fabry病诊断中的应用[J].山东大学学报(医学版),2006,44(10):1065-1068. 被引量:2
  • 5陈佳韵,潘晓霞,吕轶伦,王朝晖,王伟铭,任红,张文,翁崎峻,陈楠.11个Fabry病家系的α-半乳糖苷酶A活性及GLA基因检测[J].中华肾脏病杂志,2007,23(5):302-307. 被引量:17
  • 6Sheu SS, Chan LP, Liao SC, et al. Fabry's disease: clinical, pathologic and biochemical manifestations in two chinese males. Zhonghua Yi Xue Za Zhi( Taipei ), 1994,54:368-372.
  • 7Linthorst GE, Vedder AC, Aerts JM, et al. Screening for Fabry disease using whole blood spots fails to identify one-third of female carriers. Clin Chim Acta,2005 ,353 :201-203.
  • 8Masson C, Cisse I, Simon V, et al. Fabry disease: a review. Joint Bone Spine,2004,71:381-383.
  • 9MacDermot KD, Holmes A, Miners AH. Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females. J Med Genet,2001,38 :769-775.
  • 10Hoffmann B, Beck M, Sunder-Plassmann G, et al. Nature and prevalence of pain in Fabry disease and its response to enzyme replacement therapy-a retrospective analysis from the Fabry Out-come Survey. Clin J Pain,2007,23:535-542.

引证文献7

二级引证文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部